Belgium· BE-AMP-SAM202851-00
Typherix 25 µg/0,5 ml
A typhus, gereinigtes polysaccharid-antigen product containing salmonella typhi polyosides capsulaires vi, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Typhus, gereinigtes polysaccharid-antigen is registered in 9 of 19 countries.
Countries holding a registration under ATC J07AP03 (typhus, gereinigtes polysaccharid-antigen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Typhus, gereinigtes polysaccharid-antigen · ATC J07AP03
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Salmonella Typhi Polyosides Capsulaires Vi
- Manufacturer
- GlaxoSmithKline Biologicals
- Country
- Belgium (BE)
- ATC code
- J07AP03
- ATC class
- Typhus, gereinigtes Polysaccharid-Antigen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1460369
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AP03
Typhus, gereinigtes polysaccharid-antigen, as other registers publish it.
- FinlandTypherixGlaxoSmithKline Biologicals SA
- DenmarkTyphim ViOrifarm A/S
- FinlandTyphim ViSanofi Winthrop Industrie
- DenmarkTyphim ViParanova Danmark ApS
- IcelandTyphim ViSanofi Winthrop Industrie
- IcelandTyphim ViSanofi Winthrop Industrie
- NorwayTyphim ViSanofi Winthrop Industrie
- NorwayTyphim ViSanofi Pasteur
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e92a31a7-d7ac-4158-97d4-0658894a0e4d GET /v1/drugs/e92a31a7-d7ac-4158-97d4-0658894a0e4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Typherix 25 µg/0,5 ml",
"name_fr": "Typherix 25 µg/0,5 ml",
"name_nl": "Typherix 25 µg/0,5 ml",
"amp_code": "SAM202851-00",
"strengths": [
"25.0000"
],
"pack_count": 4,
"substances": [
"Salmonella Typhi Polyosides Capsulaires Vi"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Typhoid, Purified Polysaccharide Antigen",
"authorisation_numbers": [
"BE202851"
]
}See everything about typhus, gereinigtes polysaccharid-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.